WCK 5222

DRUG2 trials

Sponsors

Wockhardt

Conditions

QT/QTc Interval in Healthy VolunteersRenal Impairment

Phase 1

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

CompletedNCT02942810

WockhardtRenal Impairment

Start: 2016-10-25End: 2017-04-30Updated: 2018-08-02

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

CompletedNCT03554304

WockhardtQT/QTc Interval in Healthy Volunteers

Start: 2017-02-09End: 2017-10-06Updated: 2018-06-13

Related Papers

Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment.

2018-12-2126 citations